Home/Filings/4/0000874716-25-000126
4//SEC Filing

MAZELSKY JONATHAN JAY 4

Accession 0000874716-25-000126

CIK 0000874716other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 8:38 PM ET

Size

24.9 KB

Accession

0000874716-25-000126

Insider Transaction Report

Form 4
Period: 2025-08-06
MAZELSKY JONATHAN JAY
Executive Vice President
Transactions
  • Exercise/Conversion

    Common Stock

    2025-08-06$67.85/sh+29,260$1,985,291112,571.302 total
  • Sale

    Common Stock

    2025-08-06$628.27/sh1,525$958,115109,951.302 total
  • Sale

    Common Stock

    2025-08-06$630.59/sh6,056$3,818,874100,498.302 total
  • Sale

    Common Stock

    2025-08-06$639.37/sh660$421,98583,311.302 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right-to-buy)

    2025-08-0629,2600 total
    Exercise: $67.85Exp: 2026-02-13Common Stock (29,260 underlying)
  • Sale

    Common Stock

    2025-08-06$632.56/sh3,000$1,897,68990,199.302 total
  • Sale

    Common Stock

    2025-08-06$636.15/sh1,822$1,159,06884,851.302 total
  • Sale

    Common Stock

    2025-08-06$626.90/sh1,095$686,458111,476.302 total
  • Sale

    Common Stock

    2025-08-06$629.82/sh3,397$2,139,508106,554.302 total
  • Sale

    Common Stock

    2025-08-06$631.61/sh7,299$4,610,09693,199.302 total
  • Sale

    Common Stock

    2025-08-06$635.13/sh3,526$2,239,45786,673.302 total
  • Sale

    Common Stock

    2025-08-06$636.81/sh880$560,39183,971.302 total
Footnotes (13)
  • [F1]Includes 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
  • [F10]Represents the weighted average price of the shares sold ranging from a low of $636.66 to a high of $637.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F11]Represents the weighted average price of the shares sold ranging from a low of $639.235 to a high of 639.49 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F12]Grant of option to buy 41,260 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2017.
  • [F13]Not applicable
  • [F2]Represents the weighted average price of the shares sold ranging from a low of $626.585 to a high of $627.44 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F3]Represents the weighted average price of the shares sold ranging from a low of $627.72 to a high of $628.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F4]Represents the weighted average price of the shares sold ranging from a low of $629.14 to a high of $630.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F5]Represents the weighted average price of the shares sold ranging from a low of $630.14 to a high of $630.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F6]Represents the weighted average price of the shares sold ranging from a low of $631.26 to a high of $632.15 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F7]Represents the weighted average price of the shares sold ranging from a low of $632.41 to a high of $633.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F8]Represents the weighted average price of the shares sold ranging from a low of $634.66 to a high of $635.64 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
  • [F9]Represents the weighted average price of the shares sold ranging from a low of $635.66 to a high of $636.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001556270

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 8:38 PM ET
Size
24.9 KB